Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effective Factors in Door-To-Needle Time for Streptokinase Administration in Patients With Acute Myocardial Infarction Admitted to the Emergency Department Publisher



Omraninava A1 ; Hashemian AM2 ; Masoumi B3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Emergency Medicine, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran
  2. 2. Department of Emergency Medicine, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Department of Emergency Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Trauma Monthly Published:2016


Abstract

Background: Cardiovascular incidents are a common cause of death around the world. Acute myocardial infarction (AMI) poses high risks for the patient due to plaque rupture or erosion along with a superimposed non-occlusive thrombus; therefore, timely treatment with antithrombotic agents plays a key role in reducing an AMI mortality rate. Objectives: The present study aimed to assess the time interval between the admission of AMI-suspected patients and treatment initiation. Patients and Methods: This cross-sectional study was conducted on 110 patients admitted to the emergency department of Imam Hussein hospital in Tehran, Iran. Data were collected using checklists, completed by the patients' next of kin or the emergency staff. To analyze the data, student t- test and analysis of variance were used. Results: In this study, 31 female and 79 male subjects were included, respectively. The mean time to receive the first dose of streptokinase was 66.39 minutes (73.74 minutes for females and 63.5 minutes for male patients), varying from 49.92 minutes in the morning to 69.78 minutes in the afternoon and 72.68 minutes during night shifts. Conclusions: The door-to-needle (DTN) time, in a standard setting, is recommended to be less than 30 minutes. According to the results of this study, the DTN time is comparatively two times longer in females and afternoon and night shifts. Different variables including emergency staff, physicians, patients' characteristics, and environmental/physical factors induced this difference. Copyright © 2016, Trauma Monthly.
Related Docs
View other Related Docs
1. Evaluation of Fibrinolytic Medical Therapy for Patients With Acute Myocardial Infarction, ARYA Atherosclerosis (2012)
2. Non-Administration of Thrombolytic Agents in Acute Myocardial Infarction Patients in Hajar Hospital, Shahrekord, Iran: Prevalence Rate and Causes, ARYA Atherosclerosis (2013)
3. Effectiveness of Tenecteplase Versus Streptokinase in Treatment of Acute Myocardial Infarction: A Meta-Analysis, Tehran University Medical Journal (2018)
4. Background and Design of a 5-Year St Elevation Myocardial Infarction Cohort in Isfahan, Iran: Semi-Ci Study, ARYA Atherosclerosis (2022)
5. Effect of Streptokinase on Short-Term Outcomes in the Acute Myocardial Infarction With St-Segment Elevation, Journal of Reports in Pharmaceutical Sciences (2014)
6. Incidence of Neurological Syndromes After Thrombolytic Therapy in Elderly Patients With Acute Myocardial Infarction, Journal of Isfahan Medical School (2008)
7. Correaltion of Thrombolysis in Myocardial Infarction Risk Score and Angiographic Score in Patients With St-Elevation in Myocardial Infarction, Journal of Isfahan Medical School (2009)
8. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
Experts (# of related papers)
View all Related Experts
Masoumeh Sadeghi (42)
Nizal Sarrafzadegan (26)
Other Related Docs
9. The Pattern of In-Hospital Mortality of Myocardial Infarction and Associated Factors in Iran: A National Study, Journal of Isfahan Medical School (2015)
10. Evaluating the Guidelines Adherence in the Management of Nste-Acs Referred to Shahid Chamran Hospital Within Six-Month Period in 2021: A Brief Report; [بررسی تطابق دارودرمانی بیماران دچار حمله قلبی Nste-Acs مراجعه کرده به بیمارستان شهید چمران اصفهان با گایدلاین مربوطه در شش ماهه اول سال 1400: یک گزارش کوتاه], Tehran University Medical Journal (2023)
11. Apixaban, a Novel Oral Anticoagulant, Use to Resolute Arterial Patency in Radial Artery Occlusion Due to Cardiac Catheterization; a Pilot Randomized Clinical Trial, ARYA Atherosclerosis (2023)
12. Fibrinolytic Therapy in Thrombosis of Mechanical Valves: Outcomes and Complications, ARYA Atherosclerosis (2023)
13. On-Admission Versus In-Hospital Thromboembolism Due to Covid-19 Infection. What Is the Particular Characteristic of Those With Early Thrombotic Events?, Advances in Respiratory Medicine (2021)
14. A Cardiovascular Risk Assessment Model According to Behavioral, Psychosocial and Traditional Factors in Patients With St-Segment Elevation Myocardial Infarction (Cras-Mi): Review of Literature and Methodology of a Multi-Center Cohort Study, Current Problems in Cardiology (2023)
15. Persian Registry of Cardiovascular Disease (Prove): Design and Methodology, ARYA Atherosclerosis (2017)
16. Evaluation of Quality of Life in Ischemic Stroke Patients Treated With Tissue Plasminogen Activator; [بررسی کیفیت زندگی بیماران سکته ی مغسی ایسکمیک درمان شده با فعال کننده ی پلاسمینوشن بافتی], Journal of Isfahan Medical School (2023)
17. The Frequency of Antithrombotic Therapy in Management of Non-Valvular Atrial Fibrillation in Hospitalized Patients, Journal of Isfahan Medical School (2023)
18. The Association Between Platelet-To-Lymphocyte Ratio With Mortality Among Patients Suffering From Acute Decompensated Heart Failure, BMC Cardiovascular Disorders (2021)
19. The Effect of Intracoronary Versus Intralesional Injection of Eptifibatide on Myocardial Perfusion Outcomes During Primary Percutaneous Coronary Intervention in Acute St-Segment Elevation Myocardial Infarction; a Randomized Clinical Trial Study, ARYA Atherosclerosis (2019)
20. The Effect of Zolpidem or Promethazine Premedication on Agitation, Sedation and Cognitive Disorders Before and After Coronary Artery Bypass Graft Surgery, Journal of Isfahan Medical School (2015)
21. Evaluation of the Effect of Adherence to Treatment Regimen Program on Quality of Life in Atrial Fibrillation Patients Hospitalized in Shahid Chamran Hospital in Isfahan in 2017, Revista Latinoamericana de Hipertension (2019)
22. Long-Term Clinical Outcomes of the Left Ventricular Thrombus in Patients With St Elevation Anterior Myocardial Infarction, ARYA Atherosclerosis (2015)
23. Short-Time Survival Rate of Acute Myocardial Infarction in Elderly Patients in Isfahan City, Iran, Journal of Isfahan Medical School (2014)
24. Cardiovascular Disease in the Eastern Mediterranean Region: Epidemiology and Risk Factor Burden, Nature Reviews Cardiology (2018)
25. The Prediction Role of D-Dimer in Recurrence of Venous Thromboembolism 1-Year After Anticoagulation Discontinuing Following Idiopathic Deep Vein Thrombosis, Journal of Research in Medical Sciences (2014)
26. Anti-Streptokinase Antibody Detection Before and Immediately After Streptokinase Therapy in Patients With Myocardial Infarction, Iranian Journal of Immunology (2006)
27. Aspirin Resistance Status As Determined by Urinary Thromboxane B 2 (Txb2) Level in Patients With Ischemic Heart Disease and Its Relationship With Severity of Coronary Artery Disease, Journal of Isfahan Medical School (2011)
28. Reperfusion Therapies and In-Hospital Outcomes for St-Elevation Myocardial Infarction in Europe: The Acvc-Eapci Eorp Stemi Registry of the European Society of Cardiology, European Heart Journal (2021)
29. Secular Trends in Cardiovascular Mortality in Iran, With Special Reference to Isfahan, Acta Cardiologica (1999)
30. Seasonal Pattern in Admissions and Mortality From Acute Myocardial Infarction in Elderly Patients in Isfahan, Iran, ARYA Atherosclerosis (2014)
31. The Effects of Trinitroglycerin Injection on Early Complications of Angiography, ARYA Atherosclerosis (2012)
32. Prediction of Short-Term Clinical Outcome of Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Through Myeloperoxidase Levels, ARYA Atherosclerosis (2014)
33. Factors Affecting Outcome of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction, ARYA Atherosclerosis (2013)
34. Comparing Efficacy of Receiving Different Doses of Eptifibatide in Bleeding After Percutaneous Coronary Intervention in Patients With Myocardial Infarction, ARYA Atherosclerosis (2019)
35. Current Status of the Clinical Epidemiology of Myocardial Infarction in Men and Women: A National Cross-Sectional Study in Iran, International Journal of Preventive Medicine (2015)
36. Impact of Allopurinol Pretreatment on Coronary Blood Flow and Revascularization Outcomes After Percutaneous Coronary Intervention in Acute Stemi Patients: A Randomized Double Blind Clinical Trial, ARYA Atherosclerosis (2023)
37. The Comparison of Procedural and Clinical Outcomes of Thrombolytic-Facilitated and Primary Percutaneous Coronary Intervention in Patients With Acute St-Elevation Myocardial Infarction (Stemi): Findings From Prove/Acs Study, ARYA Atherosclerosis (2020)
38. Heart Rate and Cardiovascular Events: A Nested Case-Control in Isfahan Cohort Study, Archives of Iranian Medicine (2014)
39. Analysis of Traditional Risk Factors on St-Segment Elevation Myocardial Infarction Characteristics; [بررسی عوامل خطر سنتی مرتبط با ویژگیهای بالینی بیماران انفارکتوس میوکارد با بالارونده قطعه St], Journal of Isfahan Medical School (2024)
40. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)
41. Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting, Global Heart (2024)
42. Utilization and Prescribing Pattern of Rivaroxaban in a Large Teaching Hospital in Iran, Iranian Journal of Pharmaceutical Sciences (2021)
43. Development of the First Iranian Clinical Practice Guidelines for the Diagnosis, Treatment, and Secondary Prevention of Acute Coronary Syndrome, Journal of Research in Medical Sciences (2024)
44. Determination of Characteristics and Data Elements Requirements in National Acute Coronary Syndrome Registries for Postdischarge Follow-Up, Current Problems in Cardiology (2023)
45. The Role of Manual Thrombectomy in Cardiovascular Outcome Among Patients With Total Cutoff Vessel Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention, ARYA Atherosclerosis (2017)
46. Evaluation of Rivaroxaban Versus Warfarin for the Treatment of Cerebral Vein Thrombosis: A Case-Control Blinded Study, Current Journal of Neurology (2021)
47. The Evaluation of Left Ventricular Diastolic Dysfunction in Patients With Non-Hemorrhagic Stroke and Atrial Fibrillation, ARYA Atherosclerosis (2017)
48. Predictive Factors of Short-Term Survival From Acute Myocardial Infarction in Early and Late Patients in Isfahan and Najafabad, Iran, ARYA Atherosclerosis (2016)
49. Incidence of Cardiovascular Diseases in an Iranian Population: The Isfahan Cohort Study, Archives of Iranian Medicine (2013)
50. Long-Term Hospital Readmission After St-Elevation Myocardial Infarction: A 3-Year Follow-Up From the Semi-Ci Study, Journal of Tehran University Heart Center (2022)